Get started
Author

Michael Colacci

Observed names: Colacci, Michael, M Colacci, MICHAEL COLACCI, Michael Colacci (Pro)
Observed institutions: Northwestern University, St. Michael's Hospital, University Health Network, University of Toronto, Gentofte Hospital, St Michael’s Hospital, Sinai Health System, Unity Health Toronto
ORCID: 0000-0003-4898-6684
Observed ORCID: 0000-0003-4898-6684
OpenAlex ID: A5023172020
Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice
2020 · Michael Fralick, Michael Colacci, et al. · Annals of Internal Medicine · 103
Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)
2022 · M Fralick, M Colacci, et al. · BMJ · 100
Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis
2021 · Michael Colacci, John Fralick, et al. · Canadian Journal of Diabetes · 94
PDF
Oral Anticoagulant Utilization in the United States and United Kingdom
2020 · Michael Colacci, Eric K. Tseng, et al. · Journal of General Internal Medicine · 81
PDF
Sociodemographic bias in clinical machine learning models: a scoping review of algorithmic bias instances and mechanisms
2024 · Michael Colacci, Yu Qing Huang, et al. · Journal of Clinical Epidemiology · 48
Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis
2020 · Michael Fralick, Michael Colacci, et al. · Journal of Diabetes and its Complications · 38
Clinical evaluation of a machine learning–based early warning system for patient deterioration
2024 · Amol A. Verma, Therese A. Stukel, et al. · Canadian Medical Association Journal · 37
PDF
Growth and Development in Extremely Low Birth Weight Infants After the Introduction of Exclusive Human Milk Feedings
2016 · Michael Colacci, Karna Murthy, et al. · American Journal of Perinatology · 30
Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of heart failure: A nationwide cohort study of older adults with diabetes mellitus
2020 · Michael Fralick, Michael Colacci, et al. · Diabetes Obesity and Metabolism · 27
Modern-day scurvy
2020 · Michael Colacci, Wayne L. Gold, et al. · Canadian Medical Association Journal · 22
PDF
An Update to the Kaiser Permanente Inpatient Risk Adjustment Methodology Accurately Predicts In-Hospital Mortality: a Retrospective Cohort Study
2023 · Surain B. Roberts, Michael Colacci, et al. · Journal of General Internal Medicine · 20
PDF
C-terminal region of teneurin-1 co-localizes with the dystroglycan complex in adult mouse testes and regulates testicular size and testosterone production
2013 · Dhan Chand, Michael Colacci, et al. · Histochemistry and Cell Biology · 16
Validation of the Diagnostic Accuracy Levels of International Classification of Diseases, 10th Revision Codes for Diabetic Ketoacidosis: A Multicentre, Cross-sectional Study of Adults
2024 · Benazir Hodzic-Santor, Michael Colacci, et al. · Canadian Journal of Diabetes · 15
Development and external validation of tools for categorizing diagnosis codes in international hospital data
2024 · Sarah L. Malecki, Anne Loffler, et al. · International Journal of Medical Informatics · 14
Characterization of the teneurin C-terminal associated peptide (TCAP) in the vase tunicate, Ciona intestinalis: A novel peptide system associated with energy metabolism and reproduction
2015 · Michael Colacci, Reuben De Almeida, et al. · General and Comparative Endocrinology · 13
Patient Complexity, Social Factors, and Hospitalization Outcomes at Academic and Community Hospitals
2025 · Michael Colacci, Anne Loffler, et al. · JAMA Network Open · 12
PDF
Association Between SGLT2 Inhibitor Use and Change in Hemoglobin Among Adults with Diabetes: A Nationwide Cohort Study
2024 · Mats C. Højbjerg Lassen, Michael Colacci, et al. · Journal of General Internal Medicine · 9
PDF
Demographics, medication use, and admission characteristics of patients hospitalized with diabetes in Ontario, Canada: A retrospective cohort study
2024 · Michael Colacci, Afsaneh Raissi, et al. · PLoS ONE · 8
Association of sodium glucose co-transporter-2 inhibitors with risk of diabetic ketoacidosis among hospitalized patients: A multicentre cohort study
2024 · Shohinee Sarma, Benazir Hodzic-Santor, et al. · Journal of Diabetes and its Complications · 8
Tools for categorization of diagnostic codes in hospital data: Operationalizing CCSR into a patient data repository
2022 · Sarah Malecki, Anne Loffler, et al. · medRxiv · 6
PDF
Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonist use in hospital among adults with diabetes
2024 · Ashley Raudanskis, Shohinee Sarma, et al. · Journal of Diabetes and its Complications · 5
Non-ABO red cell antibodies and risk of COVID-19
2021 · Joel G. Ray, Michael Colacci, et al. · International Journal of Infectious Diseases · 5
PDF
Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study
2025 · Michael Fralick, Mats C. Højbjerg Lassen, et al. · Journal of Diabetes and its Complications · 4
Methodological progress note: Utilizing inpatient data sources to minimize common biases when emulating target trials
2023 · Michael Colacci, Michael Fralick · Journal of Hospital Medicine · 3
PDF
Response: Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis
2021 · Michael Colacci, Michael Fralick · Canadian Journal of Diabetes · 3
Works count: 58
Citation count: 739
H-index: 14
I10-index: 16
Year
Topic
Type